Journal of Chinese Integrative Medicine ›› 2006, Vol. 4 ›› Issue (1): 1-64.doi: 10.3736/jcim20060101
• Editorial • Next Articles
CLC Number:
[1] | 刘建平 . 中医药研究随机对照试验质量的现状及对策[J]. 中国中西医结合杂志, 2003,23(1):62-64 |
[2] |
詹思远, 唐金陵, 谢立亚 , 等. 中医药学术期刊随机对照临床试验文章评阅及建议[J]. 中国中西医结合杂志, 1999,19(9):568
doi: 10.7661/CJIM.1999.9.568 |
[3] | Liu JP, Kjaergard LL, Gluud C . Misuse of randomization: a review of Chinese randomized trials of herbal medicines for chronic hepatitis B[J]. Am J Chin Med, 2002,30(1):173-176 |
[4] | 刘建平 . 临床试验随机化的概念与方法[J]. 中国中西医结合杂志, 2003,23(4):244-246 |
[5] | Schulz KF, Chalmers I, Hayes RJ , et al. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials[J]. JAMA, 1995,273(5):408-412 |
[6] | Jadad A. Randomized controlled trials(1st ed)[M]. London: BMJ Publishing Group, 1998,( 1st ed):1-9 |
[7] | World Medical Association . Declaration of Helsinki: ethical principles for medical research involving human subjects[J]. JAMA, 2000,284(23):3043-3045 |
[8] |
刘建平 . 中医药临床试验的对照与盲法设置[J]. 中国中西医结合杂志, 2003,23(10):789-791
doi: 10.7661/CJIM.2003.10.789 |
[9] |
Juni P, Altman DG, Egger M . Systematic reviews in health care: Assessing the quality of controlled clinical trials[J]. BMJ, 2001,323(7303):42-46
doi: 10.1136/bmj.323.7303.42 pmid: 11440947 |
[10] |
刘建平 . 临床试验样本含量的计算[J]. 中国中西医结合杂志, 2003,23(7):536-538
doi: 10.7661/CJIM.2003.7.536 |
[11] | 刘建平 . 临床试验效应的表达——指标及其意义[J]. 中国中西医结合杂志, 2004,24(8):677-679 |
[12] | 刘建平 . 随机对照试验的依从性和意向性治疗分析[J]. 中国中西医结合杂志, 2003,23(12):884-886 |
[1] | Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283. |
[2] | Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384. |
[3] | Cai-lian Fana, Wan-jun Caib, Meng-nan Ye, Miao Chen, Yi Dai. Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro. Journal of Integrative Medicine, 2022, 20(4): 365-375. |
[4] | Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364. |
[5] | Vibha Malhotra, Joanna Harnett, Erica McIntyre, Amie Steel, Keith Wong, Bandana Saini. To “tell or not to tell”—Exploring disclosure about medicine use by people living with sleep disorders. Journal of Integrative Medicine, 2022, 20(4): 338-347. |
[6] | Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236. |
[7] | Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192. |
[8] | Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212. |
[9] | Tareq A. Wani, Zahoor A. Kaloo, Nisar A. Dangroo. Aconitum heterophyllum Wall. ex Royle: A critically endangered medicinal herb with rich potential for use in medicine. Journal of Integrative Medicine, 2022, 20(2): 104-113. |
[10] | Mohammad Fazil, Sadia Nikhat. Why the “sugars” in traditional Unani formulations are a pivotal component: A viewpoint perspective. Journal of Integrative Medicine, 2022, 20(2): 91-95. |
[11] | Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134. |
[12] | Deng-chao Wang, Miao Yu, Wen-xian Xie, Li-yan Huang, Jian Wei, Yue-hua Lei. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. Journal of Integrative Medicine, 2022, 20(1): 26-33. |
[13] | Mahlagha Dehghan, Alireza Ghanbari, Fatemeh Ghaedi Heidari, Parvin Mangalian, Mohammad Ali Zakerid. Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran. Journal of Integrative Medicine, 2022, 20(1): 45-51. |
[14] | Jose Antonio Castilla-Jimena, Isabel Ruiz-Pérez, Jesús Henares-Montiel. Impact of socioeconomic and health-related factors on consumption of homeopathic and natural remedies in Spain in 2006, 2011 and 2017. Journal of Integrative Medicine, 2022, 20(1): 52-56. |
[15] | Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64. |
|